The brain's energy economy may hold unexpected keys to addressing psychiatric disorders that have long puzzled researchers. When cellular fuel delivery falters between brain cells, the cognitive and social symptoms characteristic of schizophrenia may emerge through disrupted metabolic pathways rather than purely neurotransmitter imbalances.
This investigation examined mice engineered with four copies of the glycine decarboxylase gene, creating animals that exhibit schizophrenia-like behaviors including memory problems, sensory processing deficits, and reduced social interaction. A single injection of L-lactate one hour before testing completely normalized these behavioral abnormalities. The metabolic intervention also restored levels of PGC1α, which controls mitochondrial energy production, and brain-derived neurotrophic factor (BDNF), essential for neural plasticity and learning.
The findings illuminate how astrocytes, the brain's support cells, may contribute to psychiatric illness through disrupted lactate shuttling to neurons. This astrocyte-neuron metabolic coupling has emerged as a critical mechanism in brain health, with lactate serving as a preferred neuronal fuel during high-energy demands like learning and memory formation. The research suggests that metabolic dysfunction, rather than solely neurotransmitter abnormalities, may drive core symptoms of schizophrenia. However, translating these acute effects from genetically modified mice to human psychiatric treatment remains a significant leap. The work represents early-stage mechanistic research that could eventually inform metabolic approaches to mental health, though clinical applications would require extensive human trials to establish safety and efficacy protocols.